Search results for: gonorrhoea

Showing 1 - 10 of 22 results

25 October 2022

Griffith University and LimmaTech Biologics sign landmark deal to develop gonorrhoea vaccine

Millions of lives are set to be changed for the better thanks to a landmark deal between Griffith University and Swiss-based company LimmaTech Biologics AG to develop a world-first gonorrhoea vaccine.

Read More
24 June 2020

Researchers from Institute for Glycomics fight antibiotic-resistant gonorrhoea

A research project by Griffith University’s Institute for Glycomics seeks to identify and develop new drugs and a vaccine to...

Read More
6 March 2020
Read More
10 December 2019

Meningococcal vaccine may reduce gonorrhoea incidence

A world-first trial for a promising gonorrhoea vaccine will be led by Griffith University’s Institute for Glycomics and the Kirby...

Read More
14 May 2019

Institute for Glycomics shares in multi-million dollar grant for ground-breaking gonorrhoea research

The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), has announced awards...

Read More
20 December 2018
Read More
15 December 2023
Read More
22 June 2023

Vaginal microbes could lead to a better understanding of HIV

Vaginal microbes are at the centre of a novel discovery that aims to investigate if these bacteria trap HIV or act as a courier service to deliver the virus to the host within the human body.

Read More
14 October 2022
Read More
19 January 2022

Developing new antibiotics to treat drug resistant infections

Institute for Glycomics researchers awarded $1.1 million from NHMRC to develop new antibiotics for drug resistant gonorrhoea.

Read More